Karius

Redwood City, United States Founded: 2014 • Age: 12 yrs
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
Request Access

About Karius

Karius is a company based in Redwood City (United States) founded in 2014 by Tim Blauwkamp.. Karius has raised $315 million across 5 funding rounds from investors including Tencent, Lightspeed Venture Partners and Khosla Ventures. Karius offers products and services including Karius Spectrum. Karius operates in a competitive market with competitors including Prenetics, Inflammatix, Day Zero Diagnostics, MeMed and Visby Medical, among others.

  • Headquarter Redwood City, United States
  • Founders Tim Blauwkamp
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Karius, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Health Technology & Digital Health
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $315 M (USD)

    in 5 rounds

  • Latest Funding Round
    $100 M (USD), Series C

    May 02, 2024

  • Investors
    Tencent

    & 14 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Karius

Karius offers a comprehensive portfolio of products and services, including Karius Spectrum. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Non-invasive blood test detecting pathogens for infectious disease diagnosis.

People of Karius
Headcount 50-200
Employee Profiles 90
Board Members and Advisors 4
Employee Profiles
People
Huy Quach
Sr. Clinical Laboratory Scientist, General Supervisor,technical Specialist
People
Tim Blauwkamp
Chief Scientific Officer
People
Stacy Solorio
Chief People Officer
People
Sivan Bercovici
Chief Technology Officer & Chief Business Officer

Unlock access to complete

Board Members and Advisors
people
Steven Quake
Scientific Advisor
people
Iwijn De Vlaminck
Scientific Advisor
people
David Relman
Scientific Advisor
people
Russ Altman
Scientific Advisor

Unlock access to complete

Funding Insights of Karius

Karius has successfully raised a total of $315M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $100 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Series C — $100.0M
  • First Round
  • Investors Count 15
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2024 Amount Series C - Karius Valuation Khosla Ventures
Feb, 2020 Amount Series B - Karius Valuation SoftBank Vision Fund
Nov, 2018 Amount Debt – Conventional - Karius Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Karius

Karius has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include Tencent, Lightspeed Venture Partners and Khosla Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early-stage startups are funded by this venture capital firm.
Founded Year Domain Location
Venture capital fund backed incubator focused on the healthcare startups
Founded Year Domain Location
Private equity and venture captial firm focused on healthcare sectors
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Karius

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Karius

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Karius Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Karius

Karius operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, Inflammatix, Day Zero Diagnostics, MeMed and Visby Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Health risks are identified through online genetic and diagnostic testing.
domain founded_year HQ Location
Provider of diagnostic solutions for systemic infections
domain founded_year HQ Location
Genome sequencing diagnostics for infectious diseases are developed.
domain founded_year HQ Location
Provider of machine learning based diagnostic solutions for infectious diseases
domain founded_year HQ Location
Portable PCR diagnostics for infectious diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Karius

Frequently Asked Questions about Karius

When was Karius founded?

Karius was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Where is Karius located?

Karius is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.

Who is the current CEO of Karius?

Alec Ford is the current CEO of Karius.

Is Karius a funded company?

Karius is a funded company, having raised a total of $315M across 5 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $25M, raised on Sep 20, 2016.

What does Karius do?

Karius was founded in 2014 and is headquartered in Redwood City, United States. The company operates in the health technology sector, focusing on diagnostics for infectious diseases. A single blood sample is analyzed through the Karius Test, which employs genomics and artificial intelligence to identify microbial pathogens. This approach supports clinicians in making informed treatment decisions quickly, without invasive procedures.

Who are the top competitors of Karius?

Karius's top competitors include Visby Medical, Inflammatix and Prenetics.

What products or services does Karius offer?

Karius offers Karius Spectrum.

Who are Karius's investors?

Karius has 15 investors. Key investors include Tencent, Lightspeed Venture Partners, Khosla Ventures, Oxford Finance, and SoftBank Vision Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available